Farms.com Home   News

Re-thinking the future of labour in Canadian agriculture

What do farmers have in common with high-tech solutions, software and data-driven results? Everything, according to a recent RBC report, Farmer 4.0: How the coming skills revolution can transform agriculture.
 
The report highlights how Canada needs to grab hold of “the internet of farming.” It points out that Canada’s agricultural sector could be valued at $11 billion by 2030. To achieve this, the report recommends a complete re-think to ag education and focus more on both young people and a growing pool of new Canadians.
 
It says there could be as many as a 123,000-worker shortage by 2030, which comes on the heels of a looming retirement explosion from baby boomers.
 
The report was written before the COVID-19 pandemic outbreak in March, which upended food production and processing, supply chains and consumer demands. The fluid situation continues to impact agriculture, especially the workforce, where temporary foreign workers face self-isolation protocols when entering the country prior to starting work.
Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.